On January 13th, HSBC Holdings (00005) spent 54.84 million pounds to buy back 690.85 million shares.
HSBC Holdings (00005) announces that on January 13, 2025, the company spent 54... on the London Stock Exchange.
HSBC Holdings (00005) announced that on January 13, 2025, the company repurchased 6.9085 million shares on the London Stock Exchange at a cost of 54.8487 million.
On the same day, the company repurchased 2.05 million shares on the Hong Kong Stock Exchange at a cost of HK$207 million.
Related Articles
Sichuan Biokin Pharmaceutical (688506.SH): Yizekang combined with radiotherapy for the treatment of locally advanced unresectable head and neck squamous cell carcinoma and other solid tumors receives drug clinical trial approval.
Jiangxi Hungpai New Material (605366.SH) shareholder Xinyu Baolong plans to reduce its stake by no more than 1.93%.
The largest shareholder of Shanghai Haixin Group (600851.SH) intends to transfer part of the company's shares through public solicitation.
Sichuan Biokin Pharmaceutical (688506.SH): Yizekang combined with radiotherapy for the treatment of locally advanced unresectable head and neck squamous cell carcinoma and other solid tumors receives drug clinical trial approval.
Jiangxi Hungpai New Material (605366.SH) shareholder Xinyu Baolong plans to reduce its stake by no more than 1.93%.
The largest shareholder of Shanghai Haixin Group (600851.SH) intends to transfer part of the company's shares through public solicitation.
